Diminished inotropic response to amrinone in ventricular myocytes from myopathic hamsters is linked to depression of

Wei Xiong1, Gregory R Ferrier, Susan E Howlett

  • 1Department of Pharmacology, Sir Charles Tupper Medical Building, Dalhousie University, Halifax, Nova Scotia Canada B3H 4H7.

Insights

Amrinone, a phosphodiesterase-III inhibitor, enhances contractions in normal heart cells by boosting calcium release but fails to improve cardiomyopathic cells. Its positive inotropic effect relies on sarcoplasmic reticulum calcium stores, which are not restored in disease.

Area of Science:

  • Cardiovascular Physiology
  • Pharmacology
  • Cellular Biology

Background:

  • Heart failure involves depressed contractility in ventricular myocytes.
  • Phosphodiesterase-III inhibitors like amrinone are explored for cardiac dysfunction.
  • Calcium handling is critical for myocyte contraction and is often impaired in heart disease.

Purpose of the Study:

  • To investigate amrinone's effect on contraction and calcium handling in prefailure cardiomyopathic (CM) hamster ventricular myocytes.
  • To determine the mechanisms underlying amrinone's inotropic effects, specifically its interaction with Ca(2+)-induced Ca(2+) release (CICR) and L-type Ca(2+) current (I(Ca-L)).

Main Methods:

  • Ventricular myocytes from normal and cardiomyopathic hamsters were studied.
  • Cell shortening and ion currents (I(Ca-L)) were measured using voltage-clamp techniques.
  • Amrinone's effects on high-gain and low-gain CICR and sarcoplasmic reticulum (SR) Ca(2+) stores (assessed by caffeine) were evaluated.

Main Results:

  • Amrinone selectively enhanced high-gain CICR and contractions in normal myocytes, but not low-gain CICR.
  • Amrinone inhibited I(Ca-L) in normal myocytes and had a lesser inhibitory effect in CM myocytes.
  • Amrinone increased SR Ca(2+) stores in normal myocytes but not in CM myocytes, where high-gain CICR was depressed.

Conclusions:

  • Amrinone's positive inotropic effect in normal myocytes is mediated by enhanced high-gain CICR and increased SR Ca(2+) stores, not I(Ca-L) stimulation.
  • Amrinone does not restore depressed high-gain CICR or improve contractility in prefailure cardiomyopathic myocytes.
  • Restoration of amrinone's inotropic effect in CM cells was observed with forskolin, suggesting a role for adenylyl cyclase modulation.